Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Resistance to therapy in acute promyelocytic leukemia.

The New England journal of medicine - 18 Sept 2014

Lehmann-Che Jacqueline, Bally Cecile, de Thé Hugues

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Arsenic Trioxide
Share to Arsenicals
Share to Leukemia, Promyelocytic, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oncogene Proteins, Fusion

Share to Oxides

Share to Recurrence

Share to Tretinoin

Source

Identifiers

PMID: 25229938
DOI: 10.1056/NEJMc1409040

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Resistance to therapy in acute promyelocytic leukemia.PMID 25229938Read ↗

Mechanisms responsible for therapy resistance of acute myelogenous leukemia (AML).Semantic proximity Read ↗

Diagnosis and treatment of acute promyelocytic leukemiaSemantic proximity Read ↗

Non-genetic mechanisms of drug resistance in acute leukemiasSemantic proximity Read ↗

Retinoic acid resistance in acute promyelocytic leukemiaSemantic proximity Read ↗

Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.Semantic proximity Read ↗

Resistance to Arsenic Therapy in Acute Promyelocytic LeukemiaSemantic proximity Read ↗

RAS mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia.Semantic proximity Read ↗

Mechanisms of drug resistance in AML.Semantic proximity Read ↗

Overcoming resistance in chronic myelogenous leukemia.Semantic proximity Read ↗

CNS relapse in acute promyeloctyic leukemia.Semantic proximity Read ↗

Glucocorticoid Resistance in Childhood LeukemiaSemantic proximity Read ↗

Resistance to imatinib mesylate in chronic myeloid leukaemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.